HIBAPRESS
The Moroccan Agency for Blood and its Derivatives held, today Wednesday in Rabat, the second meeting of its board of directors, which was devoted to studying a set of documents and decisions related to the management of the agency, especially the annual report for the year 2025, the work program for the period from 2026 to 2028, and the estimated budget for the year 2026.
The works of this meeting, which was chaired by the Minister of Health and Social Protection, Amin Tahraoui, also constituted an opportunity to discuss the establishment of an internal audit committee, study a number of national and international partnership agreements, and make decisions related to the management of real estate properties belonging to the agency. On this occasion, Tahraoui said that the convening of the council comes in a national context characterized by a deep transformation of the health system, in line with the wise royal vision calling for the consolidation of justice and health sovereignty. He noted that the reform of the health sector is contingent on the restructuring of an organized and sovereign blood transfusion system, highlighting that achieving sovereignty in the field of blood and its derivatives is based on a comprehensive and consistent approach. He added that this approach is based on sustainable investments, strengthening coordination between all concerned actors, and strict adherence to quality, safety, and traceability standards, stressing the need to continue efforts aimed at promoting blood donation, strengthening the network of regional blood transfusion infrastructures, accelerating the digitization of procedures, as well as strengthening specialized training and research in this strategic sector. For his part, the director of the Moroccan Agency for Blood and its Derivatives, Kamal Al-Daghmi, said that this meeting was an opportunity to review the achievements for the year 2025, and to study many aspects related to the agency's activities and its development strategy. Al-Daghmi added, in a statement to the press, that this meeting enabled the strengthening of a common vision for the agency's strategic priorities in the service of national health security, reaffirming the agency's commitment to ensuring high-quality national self-sufficiency in blood and its derivatives. It is worth noting that the Moroccan Agency for Blood and its Derivatives undertakes organizational and technical tasks that include ensuring the quality and safety of blood and its derivatives, tracking distribution operations, activating the alert and monitoring system, contributing to the continuous training of health professionals, and licensing blood banks within health institutions. (MAP)
